Biora Therapeutics Home
Activate the mobile navigation
Close the mobile navigation Close
Home
  • Company
    • About
    • Quality
    • Careers
  • Platforms
    • BioJet Oral Therapeutic Delivery
    • NaviCap Targeted Therapeutic Delivery
  • Publications
  • News
    • Press Releases
    • Investor FAQs
  • Contact
Toggle the search bar
Close the mobile navigation

Publications

A novel method for collecting microbiome specimens: proof of concept in normal healthy volunteers
May 24, 2022 #SIBO & Microbiome
Evaluation of novel lab-in-a-capsule technology for SIBO diagnosis
November 23, 2020 #SIBO & Microbiome
SIBO diagnosis: clinical survey of practice patterns, unmet needs, and perception of a novel ingestible diagnostic capsule
November 9, 2020 #SIBO & Microbiome
Characterization of the bacterial makeup and quantitative distribution in patients with suspected small intestine bacterial overgrowth (SIBO): A meta-analysis
October 28, 2019 #SIBO & Microbiome
Accuracy of glucose breath testing for small intestine bacterial overgrowth (SIBO) using endoscopy aspirate cultures as a reference standard: A meta-analysis
October 28, 2019 #SIBO & Microbiome
Development of a swallowable diagnostic capsule to monitor gastrointestinal health
May 17, 2019 #SIBO & Microbiome
Development of targeted therapeutic antibodies for the treatment of inflammatory bowel disease: A proof of concept
May 17, 2019 #SIBO & Microbiome
A comparison of systemic versus targeted anti-TNFα antibody in treatment of colitis induced by adoptive transfer of CD44-/CD62L+ T-cells into RAG2-/- mice recipients
May 17, 2019 #SIBO & Microbiome

Connect with us

Email Us Biora Therapeutics Linkedin Biora Therapeutics Twitter
  • Company

    About Quality Careers

    Platforms

    BioJet Oral Therapeutic Delivery NaviCap Targeted Therapeutic Delivery
  • Publications

    BioJet Publications NaviCap Publications
  • Connect with Us

    Contact Us
    Email Us Biora Therapeutics Linkedin Biora Therapeutics Twitter
Privacy & Terms of Use Accessibility

© 2025 Biora Therapeutics, Inc. All rights reserved. Biora Therapeutics, NaviCap, BioJet, and GITrac are trademarks of Biora Therapeutics, Inc.

Precaution: investigational drug/device combination products. Currently limited by Federal law to investigational use only. Not for sale in the U.S.